Photocoagulation treatment for clinically significant radiation macular oedema

Macular oedema is a leading cause of vision loss in patients with radiation retinopathy. In an effort to find an effective treatment for this vision threatening complication, 12 eyes (eight patients) were treated with photocoagulation for clinically significant radiation macular oedema (CSRMO) defin...

Full description

Saved in:
Bibliographic Details
Published in:British journal of ophthalmology 1995-02, Vol.79 (2), p.144-149
Main Authors: Kinyoun, J L, Zamber, R W, Lawrence, B S, Barlow, W E, Arnold, A M
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Biological and medical sciences
Edema - surgery
Female
Fundus Oculi
Humans
Light Coagulation
Macula Lutea - surgery
Male
Medical sciences
Middle Aged
Ophthalmology
Radiation Injuries - etiology
Radiation Injuries - surgery
Radiotherapy - adverse effects
Retina - radiation effects
Retinal Diseases - etiology
Retinal Diseases - surgery
Retinopathies
Treatment Outcome
Visual Acuity
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Macular oedema is a leading cause of vision loss in patients with radiation retinopathy. In an effort to find an effective treatment for this vision threatening complication, 12 eyes (eight patients) were treated with photocoagulation for clinically significant radiation macular oedema (CSRMO) defined as central macular thickening, exudates threatening the macular centre, or one disc area of thickening in the macula. Median visual acuity improved from 20/100 preoperatively to 20/90 at the initial postoperative examination (mean follow up 5 months) and to 20/75 at the final postoperative examination (mean follow up 39 months). At the final postoperative examination, visual acuity had improved in eight (67%) eyes and six (50%) eyes had complete resolution of the CSRMO; two (17%) other eyes had improved anatomically in that fewer CSRMO criteria were present. These results suggest that macular photocoagulation is effective in decreasing macular oedema and improving vision in eyes with CSRMO.
ISSN:0007-1161
1468-2079
DOI:10.1136/bjo.79.2.144